Sale of Enzymatic Therapy, Inc. To Natures Way Holding Company Finalized
Summary
The combined group will create an organization with great depth of technical and scientific expertise that will market a very broad line of wellness products and natural medicines.Nature’s Way Holding Company has confirmed to its customers that all merchandising and marketing programs previously announced for both product lines will continue.Going forward, the company will focus on further acceleration of these very positive growth rates by continuing to deliver quality products that meet customer needs.### Green Bay, WI, November 13, 2008 --( PR.com )-- Representatives of the Dr. Willmar Schwabe Group, of Karlsruhe, Germany, have confirmed that corporate ownership for Enzymatic Therapy, Inc., of Green Bay, Wisconsin, was transferred on Friday, October 31, 2008.A shareholder group comprised of North Castle Partners, LLC, and members of Enzymatic Therapy Management previously owned Enzymatic Therapy, Inc.Details of the sale price are unavailable, as is information regarding the combined revenue of the entities.The North American operating platform for the Schwabe group will be named Natures Way Holding Company, and will include the entire operations of Enzymatic Therapy, Inc. and Nature’s Way Products Inc.The combined group will create an organization with great depth of technical and scientific expertise that will market a very broad line of wellness products and natural medicines.Nature’s Way Holding Company will continue to bring trusted consumer solutions forward under highly popular brand names that include Natures Way(tm), Alive(tm), Zucol(tm), Umcka(tm), Pearls(tm) Whole Body Cleanse(tm), Remifemin(R), and Enzymatic Therapy(R).Additionally, the company will continue to market professional products sold only through medical professionals under labels that include Integrative Therapeutics(R).Nature’s Way Holding Company has confirmed to its customers that all merchandising and marketing programs previously announced for both product lines will continue.Going forward, the company will focus on further acceleration of these very positive growth rates by continuing to deliver quality products that meet customer needs.### Contact Information Enzymatic Therapy Toni Weiss 920 469-1313 www.enzy.com Click here to view the list of recent Press Releases from Enzymatic Therapy, Inc. Promote Your Business Press Release Pricing Email this page to a friend